Literature DB >> 25337243

Identification of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern China.

Dan Wang1, Hao Cai1, Wen-Bo Yu1, Long Yu1.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide, especially in Eastern China where HBV infection confirmed as the most important pathological element. HBV X gene, extremely easy to mutate and integrate into hepatocytes, plays a significant role in HBV infection and HCC development. We deduced that mutations of integrated HBx gene make transformation more malignant. The aim of the study was to investigate whether there were different mutation patterns between the HCC tissues and the pericarcinoma liver tissues (PCLT) from patients with HCC in Eastern China.
METHODS: HBx genes extracted from 287 HCC tissue samples and 195 PCLT tissue samples were analyzed by sequence alignment and stratified analysis with the matched medical records.
RESULTS: Mutations occurred complicated and changeable in both HCC and PCLT. COOH-terminal truncation is more frequently found in HCC than PCLT (P < 0.05). There is no single site mutation of nucleic acid or amino acid makes distribution discrepancy between HCC and PCLT. Hydrophobic/hydrophilic character of amino acid of site 43, 47, 127, 131, 132 make distribution discrepancy between HCC and PCLT in men when stratified for gender (P < 0.05). Hydrophobic/hydrophilic character of amino acid of site 40 makes distribution discrepancy between HCC and PCLT in both male and female (P < 0.05). Hydrophobic/hydrophilic character of amino acid of site 47 and 127 make significant discrepancy among clinical stage I, II, III (P < 0.05).
CONCLUSIONS: During the infection and replication of HBV, HBx mutates to adjust itself to the hepatocyte and increase the carcinogenesis. COOH-terminal truncated HBX may play a stimulative role in HBV-related HCC carcinogenesis as well as hydrophobic/hydrophilic character changes in some specific amino acid sites.

Entities:  

Keywords:  Hepatitis B virus; X gene; hepatocellular carcinoma; mutation; pericarcinoma liver tissue

Mesh:

Substances:

Year:  2014        PMID: 25337243      PMCID: PMC4203214     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

Review 1.  Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator.

Authors:  M T Rossner
Journal:  J Med Virol       Date:  1992-02       Impact factor: 2.327

2.  Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.

Authors:  K Poussin; H Dienes; H Sirma; S Urban; M Beaugrand; D Franco; P Schirmacher; C Bréchot; P Paterlini Bréchot
Journal:  Int J Cancer       Date:  1999-02-09       Impact factor: 7.396

3.  Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

Authors:  W F Carman; M R Jacyna; S Hadziyannis; P Karayiannis; M J McGarvey; A Makris; H C Thomas
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

4.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Identification of three essential regions of hepatitis B virus X protein for trans-activation function.

Authors:  M Arii; S Takada; K Koike
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

6.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 7.  Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.

Authors:  W S Robinson
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

8.  The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway.

Authors:  E Lara-Pezzi; A L Armesilla; P L Majano; J M Redondo; M López-Cabrera
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer.

Authors:  Lu Zheng; Wei Gong; Ping Liang; XiaoBing Huang; Nan You; Ke Qiang Han; Yu Ming Li; Jing Li
Journal:  Tumour Biol       Date:  2014-01-15

10.  Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene.

Authors:  B L Slagle; T H Lee; D Medina; M J Finegold; J S Butel
Journal:  Mol Carcinog       Date:  1996-04       Impact factor: 4.784

View more
  8 in total

Review 1.  Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis.

Authors:  Ming Geng; Xuan Xin; Li-Quan Bi; Lu-Ting Zhou; Xiao-Hong Liu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 2.  Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma.

Authors:  Xin Zhang; Hui-Guo Ding
Journal:  World J Hepatol       Date:  2015-05-28

3.  E3 Ubiquitin Ligase Siah-1 is Down-regulated and Fails to Target Natural HBx Truncates for Degradation in Hepatocellular Carcinoma.

Authors:  Jing Zhao; Jing Wu; Hao Cai; Dan Wang; Long Yu; Wen-Hong Zhang
Journal:  J Cancer       Date:  2016-01-20       Impact factor: 4.207

4.  Short hairpin RNA attenuates liver fibrosis by regulating the PPAR‑γ and NF‑κB pathways in HBV‑induced liver fibrosis in mice.

Authors:  Lei Ye; Ting Chen; Jiaqi Cao; Liying Sun; Wuping Li; Chenghai Zhang
Journal:  Int J Oncol       Date:  2020-09-22       Impact factor: 5.650

5.  HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.

Authors:  Zhen Chen; Jia Tang; Xuefei Cai; Yao Huang; Qingzhu Gao; Li Liang; Ling Tian; Yi Yang; Yaqiu Zheng; Yuan Hu; Ni Tang
Journal:  Cancer Sci       Date:  2016-09-01       Impact factor: 6.716

Review 6.  Hepatitis B virus X protein in liver tumor microenvironment.

Authors:  Sha Fu; Rong-Rong Zhou; Ning Li; Yan Huang; Xue-Gong Fan
Journal:  Tumour Biol       Date:  2016-09-23

Review 7.  Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma.

Authors:  Ping An; Jinghang Xu; Yanyan Yu; Cheryl A Winkler
Journal:  Front Genet       Date:  2018-07-19       Impact factor: 4.599

Review 8.  Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.

Authors:  Yu-Min Choi; So-Young Lee; Bum-Joon Kim
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.